Log in
Enquire now
CardioCell

CardioCell

CardioCell is a biotechnology company developing stem cell therapies for improving cardiovascular health.

OverviewStructured DataIssuesContributors

Contents

stemcardiocell.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Regenerative medicine
Regenerative medicine
Immunotherapy
Immunotherapy
Cell therapy
Cell therapy
Stem cell
Stem cell
Healthcare
Healthcare
Biomedical engineering
Biomedical engineering
Technology
Technology
...
Location
United States
United States
California
California
San Diego
San Diego
B2X
B2B
B2B
0
CEO
‌
Sergey Sikora
0
Founder
‌
Sergey Sikora
0
Date Incorporated
2013
Number of Employees (Ranges)
1 – 100
Email Address
info@stemcardiocell.com
Founded Date
2013
Country
United States
United States

Other attributes

Company Operating Status
Active
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date

CardioCell Reports Positive Results From the First Phase IIa Clinical Trial Using IV Administration of Stem Cells for Chronic Heart Failure Indications

CardioCell LLC

https://www.prnewswire.com/news-releases/cardiocell-reports-positive-results-from-the-first-phase-iia-clinical-trial-using-iv-administration-of-stem-cells-for-chronic-heart-failure-indications-300318580.html

Web

CardioCell stem cells 'improve well-being' of heart failure patients | FierceBiotech

Ben Adams

https://www.fiercebiotech.com/biotech/cardiocell-stems-cells-improve-well-being-heart-failure-patients

Web

References

Find more companies like CardioCell

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.